» Articles » PMID: 30296873

Association Between Serum Copper Levels and Lung Cancer Risk: A Meta-analysis

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2018 Oct 10
PMID 30296873
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the association between serum copper levels and lung cancer risk.

Methods: We searched the electronic PubMed, WanFang, CNKI, and SinoMed databases to identify studies including information on serum copper levels and lung cancer. Standard mean differences and corresponding 95% confidence intervals were calculated using Stata 12.0 software. We performed a meta-analysis on the identified studies overall and according to geographic location. We also evaluated heterogeneity among the studies and the occurrence of publication bias.

Results: Thirty-three articles including 3026 cases and 9439 controls were included in our study. The combined results showed that serum copper levels were higher in patients with lung cancer compared with controls without lung cancer, though the results showed high heterogeneity. In a subgroup analysis according to geographic location, significant associations between copper levels and lung cancer were found for both Asian and European populations. No publication bias was detected in this meta-analysis.

Conclusions: High serum copper levels could increase the risk of lung cancer, suggesting that environmental copper exposure may be a risk factor for the development of lung cancer.

Citing Articles

Copper in colorectal cancer patients: a systematic review and meta-analysis.

Munoz-Bravo C, Marin-Burdallo I, Gonzalez-Herrera L, Gonzalez-Palacios Torres C, Lozano-Lorca M, Jimenez-Moleon J Carcinogenesis. 2025; 46(1).

PMID: 39847508 PMC: 11826919. DOI: 10.1093/carcin/bgaf001.


Construction of a cuproptosis-tricarboxylic acid cycle-associated lncRNA model to predict the prognosis of non-small cell lung cancer.

Li X, Zhao Y, Wei S, Dai Y, Yi C Transl Cancer Res. 2025; 13(12):6807-6824.

PMID: 39816567 PMC: 11729758. DOI: 10.21037/tcr-24-660.


IAPP blocks anti-breast cancer function of CD8T cells via targeting cuproptosis.

Guo D, Huang Z, Wang Q, Chen W, Huang Y, Sun X Front Immunol. 2024; 15:1481129.

PMID: 39654888 PMC: 11625781. DOI: 10.3389/fimmu.2024.1481129.


Chaperone-Derived Copper(I)-Binding Peptide Nanofibers Disrupt Copper Homeostasis in Cancer Cells.

Jeena M, Link J, Zhang J, Harley I, Turunen P, Graf R Angew Chem Int Ed Engl. 2024; 63(51):e202412477.

PMID: 39446574 PMC: 11627128. DOI: 10.1002/anie.202412477.


Trends of Copper Homeostasis in Neoplasms: A Systemic Bibliometric from 2013 to 2023.

Lin Y, Lin W, Lai Y, Chen Y Biol Trace Elem Res. 2024; .

PMID: 39379668 DOI: 10.1007/s12011-024-04413-z.


References
1.
Fisher G, Shifrine M . Hypothesis for the mechanism of elevated serum copper in cancer patients. Oncology. 1978; 35(1):22-5. DOI: 10.1159/000225249. View

2.
Begg C, Mazumdar M . Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50(4):1088-101. View

3.
Ruano-Ravina A, Figueiras A, Freire-Garabal M, Barros-Dios J . Antioxidant vitamins and risk of lung cancer. Curr Pharm Des. 2006; 12(5):599-613. DOI: 10.2174/138161206775474396. View

4.
GUBLER C, LAHEY M, CARTWRIGHT G, Wintrobe M . Studies on copper metabolism. IX. The transportation of copper in blood. J Clin Invest. 1953; 32(5):405-14. PMC: 438356. DOI: 10.1172/JCI102752. View

5.
Zowczak M, Iskra M, Paszkowski J, Manczak M, Torlinski L, Wysocka E . Oxidase activity of ceruloplasmin and concentrations of copper and zinc in serum of cancer patients. J Trace Elem Med Biol. 2002; 15(2-3):193-6. DOI: 10.1016/S0946-672X(01)80066-3. View